Correspondence cocci isolated in the U K have been between 2 and 4 mg/L, although these values are not predictive of clinical failure except in patients with meningitis.
Sir, A ntibiotic resistance amongst isolates of Salm onella enterica in E ngland and Wales is being recognized with increasing frequency. [1] [2] [3] Strains of S. enterica serovar typhim urium D T 104, which are resistant to ampicillin, chloramphenicol, streptomycin, sulphonamides and tetracycline (A CSSuT phenotype), are particularly common isolates from both animals and humans. [1] [2] [3] In 1996, 24% and 14% of these strains were also resistant to trimethoprim and ciprofloxacin, respectively. 4 We report here the in-vitro susceptibilities of 181 strains of S. enterica isolated in 1996 in seven centres in the R epublic of Ireland.
Clinical isolates were confirmed as belonging to the S. enterica group by the A PI20E system (bioMérieux, Marcy l'E toile, France) and the serotypes were determined by an agglutination technique with standard antisera (Murex, D ublin, Ireland). The strains were maintained at -70°C until studied. From the more commonly isolated serovars, 25-50% of non-replicate isolates were randomly selected; the composition of the 181 strains is summarized in the Table. Susceptibility testing was performed by a disc diffusion method according to recommendations of the National Committee for Clinical Laboratory Standards (NCCLS) 5 with E scherichia coli A TCC 25922 as a control. The antibiotics tested and the contents of the discs, which were obtained from O xoid (Basingstoke, U K), were as follows: ampicillin (10 g); chloramphenicol (30 g); streptomycin (10 g); a sulphonamide (300 g); tetracycline (30 g); trimethoprim (5 g); ciprofloxacin (5 g); and cefotaxime (30 g). In addition, the MICs of ciprofloxacin for some strains were determined by the E test method (A B Biodisk, Solna, Sweden) in accordance with the manufacturer's instructions.
The susceptibilities of the isolates to ampicillin, chloramphenicol, streptomycin, sulphonamides, tetracycline and trimethoprim are summarized in the Table; all of the strains were susceptible to cefotaxime and ciprofloxacin (data not shown). R ates of resistance to at least one of the six antibiotics mentioned above varied according to the serovar. For Salm onella enteritidis, only 4% of strains were resistant to one or more of these agents, compared with 94% for S. typhim urium . The corresponding values for the other serovars were as follows: Salm onella derby, 100% ; Salm onella virchow, 31% ; Salm onella bredeney, 38% ; Salm onella schwarz engrund, 27% ; and Salm onella agona, 33% . Thirty-seven (73% ) of the S. typhim urium strains exhibited the A CSSuT phenotype and nine of these strains were resistant to trimethoprim as well. The A CSSuT phenotype was also observed in respect of one strain of S. derby and in the single isolate of Salm onella hadar.
The data reported here demonstrate high levels of antibiotic resistance amongst S. enterica serovars, other than S. enteritidis, in the R epublic of Ireland. In particular, S. typhim urium strains exhibiting the A CSSuT phenotype, which is closely associated with D T 104, 4 now account for approximately three of every four clinical isolates of this serovar. In common with strains isolated in E ngland and Wales, resistance to trimethoprim is also common, 2,4 but, in contrast to the data from E ngland and Wales, resistance to ciprofloxacin was not observed. This discrepancy is almost certainly due to the fact that, in the former studies, a MIC resistance breakpoint for ciprofloxacin of 0.125 mg/L was used, 2,4 whereas we adopted the NCCLS interpretative criterion for the disc diffusion test which corresponds to a MIC breakpoint of 1 mg/L. 5 To test this theory, we determined the MICs of ciprofloxacin for 26 strains of S. typhim urium exhibiting the A CSSuT phenotype and for two S. virchow strains that were resistant to at least two antibiotics. While all of the S. typhim urium strains and one S. virchow strain were susceptible to ciprofloxacin, irrespective of the interpretative criterion, the second S. virchow strain was categorized as susceptible according to the NCCLS criterion and resistant according to the lower breakpoint adopted by some investigators in E ngland and Wales.
2,4
A further observation made in the course of this study in relation to streptomycin was that, for S. enterica serovars other than S. enteritidis, there was a marked clustering of the diameters of the zones of inhibition around the susceptibility breakpoint ( 15 mm). This caused almost 8% of all strains to be placed in the intermediate susceptibility category. The tri-modal distribution of the zones of inhibition was also of interest because it suggests that resistance to streptomycin amongst S. enterica isolates develops as a two-step process.
The results of the present study have demonstrated high levels of antibiotic resistance amongst most serovars of S. enterica, particularly S. typhim urium , isolated in the R epublic of Ireland. The patterns of resistance were similar to those for strains in E ngland and Wales. There is, however, a need for continuing surveillance nationally of antimicrobial resistance in clinical isolates of S. enterica. Sir, Coagulase-negative staphylococci (CNS) are important causes of infection in neonates and are often resistant to methicillin and other anti-staphylococcal antibiotics. The isolation of strains of Staphylococcus epiderm idis exhibiting reduced susceptibility to teicoplanin (MICs 4 mg/L) 1 from blood cultures obtained from patients in a paediatric tertiary referral hospital was therefore of concern and prompted prospective surveillance in order to define the prevalence of these organisms. Isolates were also assessed for epidemiological relatedness by molecular techniques.
The susceptibilities of CNS isolated from blood cultures were initially determined by the disc diffusion method according to guidelines issued by a working party of the British Society for A ntimicrobial Chemotherapy; 1 the medium used was IsoSensitest agar (O xoid, Basingstoke, U K) and the discs contained 30 g of teicoplanin. Strains for which the inhibition zone diameters were <17 mm 2 were speciated with the ID 32 STA PH system (bioMérieux, Marcy l'É toile, France) and MICs of teicoplanin and vancomycin for these isolates were determined by the E test method (A B Biodisk, Solna, Sweden) on IsoSensitest agar without additives; strains with teicoplanin MICs 4 mg/L were referred to the A ntibiotic R eference U nit of the Central Public H ealth Laboratory for confirmation of MIC. The isolates were also compared by pulsed-field gel electrophoresis (PFG E ) of Sm aI chromosomal D NA digests. D NA was prepared as described previously 3 and digested with Sm aI restriction endonuclease (Boehringer Mannheim, Mannheim, G ermany) according to the manufacturer's instructions. The restriction fragments were separated by PFG E in 1.2% agarose gels in an electric field of 6 V/cm for 45 h with pulse times ranging from 1 to 45 s.
Between July 1996 and May 1997, CNS with reduced susceptibilities to teicoplanin, all of which were identified as S. epiderm idis, were isolated from 34 blood cultures obtained from 15 patients. These represented 6.6% of all blood culture isolates and 11.4% of all CNS recovered from blood cultures during that period. The median age of the patients was 1 month (range, 1 week to 8 years). The median duration of hospital stay before isolation of a strain of S. epiderm idis with reduced susceptibility to teicoplanin (TR SE ) was 10 days (range, 0-20 days) and the median number of antibiotic days (total of the number of days during which each antibiotic was administered) was 13 (range, 0-61). No patient from whom one or more strains of TR SE were isolated had previously received teicoplanin, although five had been treated with vancomycin. In three patients, the isolates caused septicaemias. O ne of these, a 2 week old infant who had undergone surgical correction of gastroschisis, failed to respond to treatment with teicoplanin at a dosage of 7.6 mg/kg daily, but subsequently responded to a course of vancomycin. The isolates from the remaining 12 patients were regarded as skin contaminants (n = 11) or as colonizing a central catheter (n = 1).
The MICs of teicoplanin and vancomycin for the isolates ranged from 6 to 32 mg/L and 1.5 to 4 mg/L, respectively. Multiple isolates from individual patients, apart from one, exhibited identical antibiograms, although, even in the exception, PFG E confirmed that all of the isolates were variants of the same strain. For two pairs of patients, all of whom had been nursed on the intensive care unit (ICU ), the isolates were clonally related and those from a further two patients appeared to be variants of one of these strains.
CNS have emerged as important nosocomial pathogens, although, in this study, TR SE strains were confirmed as pathogens in only three of 15 (20% ) patients, all of whom had central lines. The presence of such lines is a significant risk factor for infection with S. epiderm idis, owing to the ability of this organism to produce slime and to adhere to plastic catheters. 4 Neonatal and post-surgical intensive care patients are particularly susceptible to infections caused by CNS.
5 Ten (67% ) of the patients in the present study were on the ICU at the time that strains of TR SE were isolated from them. The discovery of two pairs of
